drugset / Trial / NCT02095899

Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome

NCT02095899

Phase 2 Withdrawn University of Zurich
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test if rufinamide has an effect on chronic neuropathic pain in patients with a post thoracotomy pain syndrome.

Timeline

Start
2014-03
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rufinamide Small molecule 800 mg Oral